Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ACR Partners with Coalition, Patient Advocacy Groups to Advocate for Rheumatology

Chris Morris, MD, RheumPAC Committee  |  Issue: July 2015  |  July 13, 2015

In terms of getting our message heard in Washington, D.C., rheumatology faces a David vs. Goliath battle on several levels. Many industries have far greater resources, use multiple lobbying firms, and have advertising and lobbying budgets that eclipse ours by several hundred-fold. Rheumatology is far smaller than most other medical specialties; our membership is a small fraction of the surgeons, cardiologists and family physicians. Finally, many issues important to our specialty are not particularly germane to all of our colleagues.

Despite these roadblocks, we have a fairly good track record in Washington. One way we have succeeded is through the development and use of coalitions. The ACR is a part of several coalitions that help promote causes important to us. The Cognitive Specialties Coalition includes other internal medicine specialties that have far different goals from those specialties heavy in procedures. The Coalition for Access to Treatment supports our ability to get our patients expensive medications that are vital to their well-being and disease control at a reasonable price. We also team up with patient advocacy groups, such as the Arthritis Foundation, to promote a variety of issues important to our ability to provide the best care to those in need. Combining many small voices results in our message being heard that much better.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The legislative branch also has coalitions that are important to promoting our causes. We approach caucuses that already have some knowledge of our issues in the hopes that they can explain our issues to their colleagues who are not acquainted with the problems we and our patients face.

The Congressional Arthritis Caucus is actively promoting the Patients’ Access to Treatments Act (PATA), which aims to keep biologics affordable for our patients. The Congressional Academic Medicine Caucus (CAMC) is an informal, bipartisan group of members of Congress dedicated to advancing legislation designed to strengthen medical education in the U.S. Other caucuses might be approached by us if there is an issue that would be important to the members.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Our involvement with the various coalitions has made a difference. Rheumatologists are no longer believed to be feng shui specialists in the halls of Congress. As we make stronger ties with other like-minded groups, we can expect to see many more successes in the future.

Share: 

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:AC&RAdvocacycoalitionCongresslawmakerLegislationrheumatology

Related Articles

    The Voice of Rheumatology: The Most Important Rheumatology Coalition You’ve Never Heard Of

    July 25, 2023

    The Voice of Rheumatology was established as an informal coalition to aid effective collaborations on issues important to the rheumatology community. The group has grown to become an integral mechanism for the exchange of information among groups including the ACR, Arthritis Foundation, Coalition of State Rheumatology Organizations (CSRO), Alliance for Women in Rheumatology and more to strengthen partnerships on a range of federal, state and regulatory issues.

    Advocacy Highlights & Fall Treats: Reflections from the GAC Chair

    October 21, 2022

    Outgoing Government Affairs Committee Chair Blair Solow, MD, offers advocacy updates from 2022 and seasonal reflections on how to stay focused on efforts that matter when faced with daunting challenges.

    Advocating for CMMI Reform, Looking Ahead to Alternative Payment Models

    May 17, 2017

    The work of health policy reform is a marathon, not a sprint. The ACR is encouraged by the forward progress being made in collaboration with the American Medical Association and other physician-led organizations within the Healthcare Leaders for Accountable Innovation in Medicare and Medicaid coalition (known as the AIM coalition) to advocate for physicians’ ability…

    ACR Leads Coalition Response to HHS Proposed Drug Pricing Threats

    April 20, 2018

    Potential federal drug pricing proposals could shuffle Part B drug coverage into the Part D program and restructure reimbursements for new drugs, moves that would jeopardize patient access to care, explains Kent “Kwas” Huston, MD, a rheumatologist in Kansas City, Mo., and a member of the ACR’s Government Affairs Committee (GAC). “We believe Part D…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences